| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/02/2009 | CN101522708A Peptides having activities of epidermal growth factor and its uses |
| 09/02/2009 | CN101522707A 肌肉生长抑制素拮抗剂 Myostatin antagonists |
| 09/02/2009 | CN101522706A Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 09/02/2009 | CN101522705A Antibacterial and antiviral peptides from ACTINOMADURA NAMIBIENSIS |
| 09/02/2009 | CN101519663A Recombinant CREG protein and application thereof |
| 09/02/2009 | CN101519658A Construction and expression of vector of tumstatin T7 of tumstatin T7 peptide and derivative T7-NGR thereof |
| 09/02/2009 | CN101519657A Full-length infectious cDNA clones of tick borne flavivirus |
| 09/02/2009 | CN101519446A Method for preparing recombinant human insulin and analogs of recombinant human insulin |
| 09/02/2009 | CN101519445A Urine follicle-stimulating hormone with high specific activity and method for preparing same |
| 09/02/2009 | CN101519444A Method for preparing Nesiritide |
| 09/02/2009 | CN101519443A Method for inducing silkworms to produce antibacterial peptides by radiation or electric shock |
| 09/02/2009 | CN101519442A Method for inducing silkworms to produce antibacterial peptides |
| 09/02/2009 | CN101519441A Protein related to plant blossom time, a coding gene and applications thereof |
| 09/02/2009 | CN101519440A Intersecting protective vaccine antigen, preparation method and application thereof |
| 09/02/2009 | CN101519439A Freezeproof polypeptide, synthesis, composition containing same and application thereof |
| 09/02/2009 | CN101519367A Propoxur artificial antigen and method for synthesizing same |
| 09/02/2009 | CN101519364A Chlorine flucythrinate artificial antigen and method for synthesizing same |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN100535118C Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |
| 09/02/2009 | CN100535117C Paraquat resistance gene and a vascular tissue- and trichome-specific promotor |
| 09/02/2009 | CN100535111C Novel process for preparing recombinant Exendin-4 polypeptide |
| 09/02/2009 | CN100535007C Purification of glucagon-like peptides |
| 09/02/2009 | CN100535006C Analog of GLP-1 |
| 09/02/2009 | CN100535005C Long chain human insulin-like growth factor(LR3IGF-1) and its preparing process and application method |
| 09/02/2009 | CN100535004C Iron regulating protein-2 (IRP-2) as a diagnostic for neurodegenerative disease |
| 09/02/2009 | CN100535003C Analog of Exendin 4 |
| 09/02/2009 | CN100535002C Recombinant tubercle bacillus antigen poly epitope peptide and its constructing method and use |
| 09/02/2009 | CN100534535C Improved linkers for pharmaceutical compounds |
| 09/01/2009 | US7582816 Maize variety PHW5F |
| 09/01/2009 | US7582807 one or more nucleotide sequences of interest in transgenic plants; fusion proteins comprising a DNA binding domain fused to a recruitment factor that is capable of recruiting chromatin remodelling proteins such as HDAC and HAT, to specific DNA sites to regulate expression of a gene of interest |
| 09/01/2009 | US7582778 Podophyllotoxin |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
| 09/01/2009 | US7582732 Lymphocyte antigen 6 complex, locus H (LY6H) protein for use in treatment and prevention of neurodegenerative diseases |
| 09/01/2009 | US7582731 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 09/01/2009 | US7582730 an iron-regulated protein found in Neisseria gonorrhoeae or Neisseria meningitidis outer membranes; immunizing a host against gonococcal and meningococcal diseases, such as gonorrhea, meningitis |
| 09/01/2009 | US7582729 polypeptide comprising an amino acid sequence of a C1 bacteriophage PlyC lytic enzyme, wherein the polypeptide is a subunit PlyC lysin heavy chain (PlyC-A); multimeraic proteins; prophylactic and therapeutic use to treat or prevent Streptococcal infections |
| 09/01/2009 | US7582727 Pharmaceutical formulations of bivalirudin and processes of making the same |
| 09/01/2009 | US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
| 09/01/2009 | US7582610 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity |
| 09/01/2009 | US7582607 Has genetically engineered disulfide bonds; reduced capacity of O-glycosylation when expressed in yeast compared to wild-type human FGF-21; vectors and host cells for propagation of nucleic acid sequences; non-insulin dependent diabetes, hypoglycemic agents; hyperinsulinemia, insulin resistance, obesity |
| 09/01/2009 | US7582606 Polypeptide includes an NADPH oxidase cytosolic cofactor polypeptide NOXA1 or p67phox having a C-terminal SH3 domain insertion mutation of at least three consecutive amino acids positioned so as to reduce activity of the purified polypeptide relative to the wild-type cofactor polypeptide |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582602 Hirulog-like peptide and gene therapy |
| 09/01/2009 | US7582476 For diagnosis and treatment of estrogenic disorder of mutant ER alpha |
| 09/01/2009 | US7582466 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 09/01/2009 | US7582450 Homogeneous preparations of IL-29 produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/01/2009 | US7582449 Culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector includes a nucleic acid sequence encoding a polypeptide elicits an immune response; penumonia treatment |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582447 Sodium transport protein for use in identifying modulator for treatment of male infertility |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582439 Detecting the presence/absence of a complex of a Bim molecule (a novel member of the Bcl-2 family) and an antibody specific for a specific amino acid sequence;modulating physiological cell death or survival and/or modulating cell cycle entry; antiapoptosis; anticarcinogenic agents; autoimmune diseases |
| 09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 09/01/2009 | US7582425 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin |
| 09/01/2009 | US7582424 Genetic disorders and cholera endotoxins for calcium channel activators |
| 09/01/2009 | US7582304 Immunizing an animal against Lyme disease by administering composition of at least two OspC polypeptides from Lyme Disease causing Borrelia comprising unlipidated and lipidated OspC polypeptides |
| 09/01/2009 | US7582303 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand |
| 09/01/2009 | US7582301 Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides |
| 09/01/2009 | US7582300 Modulation of gamma delta T cells to regulate airway hyperresponsiveness |
| 09/01/2009 | US7582296 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof |
| 09/01/2009 | US7582293 Anti-PRO6308 antibodies |
| 09/01/2009 | US7582290 Use in suicide gene therapy of cancer cells and producing immunotoxins; infecting the cell with an adenovirus produced by a packaging cell line, where an adenoviral vector of a promoter is linked to a nucleic acid encoding the A subunit of diphtheria toxin A or Pseudomonas Exotoxin A, mutated EF-2 gene |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | US7581953 Interactive dental restorative network |
| 09/01/2009 | CA2327434C Dna immunization against chlamydia infection |
| 09/01/2009 | CA2283536C Compositions and methods for elimination of unwanted cells |
| 09/01/2009 | CA2281491C Zcytor7 cytokine receptor |
| 09/01/2009 | CA2274469C Serum-derived factor inducing cell differentiation and medical uses thereof |
| 09/01/2009 | CA2267653C Waxy wheat starch types having waxy proteins in granule |
| 09/01/2009 | CA2213343C Chimeric adenoviral fiber protein and methods of using same |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 09/01/2009 | CA2087614C Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
| 08/27/2009 | WO2009105786A2 Treatment for oral disease |
| 08/27/2009 | WO2009105783A1 Cosmetic and dermatological formulations of mntf peptides |
| 08/27/2009 | WO2009105780A2 Mntf peptide compositions and methods of use |
| 08/27/2009 | WO2009105671A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications |
| 08/27/2009 | WO2009105585A2 Postsynaptically targeted chemodenervation agents and their methods of use |
| 08/27/2009 | WO2009105572A2 Antisense modulation of amyloid beta protein expression |
| 08/27/2009 | WO2009105507A2 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
| 08/27/2009 | WO2009105492A2 Transgenic plants having altered nitrogen use efficiency characteristics |
| 08/27/2009 | WO2009105269A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 08/27/2009 | WO2009105141A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 08/27/2009 | WO2009105084A2 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 08/27/2009 | WO2009104964A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 08/27/2009 | WO2009104958A1 Production of itaconic acid |
| 08/27/2009 | WO2009104738A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier |
| 08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
| 08/27/2009 | WO2009104281A1 Method and gene for imparting or enhancing nonspecific adherence and/or aggregability to microorganism |
| 08/27/2009 | WO2009104199A1 A method of obtaining purified heterologous insulins expressed in yeast |
| 08/27/2009 | WO2009104188A2 Photoactive nanostructure and method of manufacturing same |
| 08/27/2009 | WO2009104097A2 Meningococcal fhbp polypeptides |
| 08/27/2009 | WO2009104001A2 Oligopeptidic compounds and uses thereof |
| 08/27/2009 | WO2009103965A1 Modified linkers |
| 08/27/2009 | WO2009103898A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/27/2009 | WO2009103838A1 Detection and quantification of cyclic imines, based on competitive binding to nicotinic acetylcholine receptors |
| 08/27/2009 | WO2009103826A1 System for producing multimeric peptides and proteins and use thereof |
| 08/27/2009 | WO2009103752A1 Protein nanocarriers, process for obtaining them and applications |
| 08/27/2009 | WO2009103741A2 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 08/27/2009 | WO2009103562A1 Method of treating ocular diseases by gene therapy |
| 08/27/2009 | WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF |